Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Red Cell Adhesion in Pediatric Sickle Cell Disease
NCT02012777Phase 1Terminated
- Sponsor
- University of Miami
- Start
- Jun 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of propranolol in sickle cell disease (SCD) (3 cohorts), sponsored by University of Miami. Primary endpoint: Measurement of the sickle red cell response to epinephrine. Started Jun 2010; status: terminated.
02
Drugs
propranolol
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02012777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012777.